Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia
Open Access
- 1 September 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (9) , 927-934
Abstract
Schizophrenia is a life-long illness that typically requires maintenance antipsychotic treatment throughout an individual’s life.1 Older age1,2 is a risk factor for antipsychotic-induced adverse effects, including parkinsonism, tardive dyskinesia, falls, and metabolic syndrome.3,4 Clinical guidelines5 developed by expert consensus recommend the use of lower doses of antipsychotics in older patients with schizophrenia. However, empirical data on age-specific antipsychotic dosing are limited.6Keywords
This publication has 29 references indexed in Scilit:
- The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohortParkinsonism & Related Disorders, 2014
- Treating Older Adults With Schizophrenia: Challenges and OpportunitiesSchizophrenia Bulletin, 2013
- Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugsThe British Journal of Psychiatry, 2012
- Age and Sex Impact Clozapine Plasma Concentrations in Inpatients and Outpatients With SchizophreniaThe American Journal of Geriatric Psychiatry, 2012
- Novel rating scales for schizophrenia — Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz)Schizophrenia Research, 2008
- Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic reviewPsychological Medicine, 2008
- Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and NeuroprotectionPharmacological Reviews, 2008
- Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region ModelNeuroImage, 1997
- Simplified Reference Tissue Model for PET Receptor StudiesNeuroImage, 1996
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989